Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MARCH 25, 2015 FBO #4869
SOLICITATION NOTICE

65 -- G-Rex Permeable Cell Culture Devices

Notice Date
3/23/2015
 
Notice Type
Presolicitation
 
NAICS
424210 — Drugs and Druggists' Sundries Merchant Wholesalers
 
Contracting Office
Department of Health and Human Services, National Institutes of Health, Clinical Center/Office of Purchasing & Contracts, 6707 Democracy Blvd, Suite 106, MSC 5480, Bethesda, Maryland, 20892-5480
 
ZIP Code
20892-5480
 
Solicitation Number
15-004134
 
Archive Date
4/16/2015
 
Point of Contact
Ivan Mallory Jones, Phone: 3014352244
 
E-Mail Address
ivan.jones@nih.gov
(ivan.jones@nih.gov)
 
Small Business Set-Aside
N/A
 
Description
This is a notice of intent, not a request for a quotation. A solicitation document will not be issued and quotations will not be requested. The National Institute of Health, Clinical Center (CC) intends to award a Fixed Price Purchase Order with a base period and one (1) one year option to Wilson Wolf Manufacturing Corporation, St. Paul, MN 55112 on a sole source basis to procure G-Rex Gas Permeable Cell Culture Devices for the purposes of continuing and completing studies with tumor infiltrating lymphocytes at the National Institutes of Health's Clinical Center, Department of Transfusion Medicine. Wilson Wolf Manufacturing Corporation is the sole manufacturer of the items in questions. G-Rex 100 flasks are unique cell culture vessels recently designed by Wilson Wolf Manufacturing. The Cell Processing Lab has shown that the culture of Tumor Infiltrating Lymphocytes (TIL), Natural Killer (NK) cells and LCL cells when using the G-Rex flasks are superior to growth bags. G-Rex flasks all for cell growth at higher densities and therefore less media, growth factors, cytokine and serum additives are required. The NIH protocols to use these flasks are Institutional Review Board (IRB) approved and in the case of INDs, has been approved by the US Food and Drug Administration for treatment of human subjects. No substitutions are permitted. This acquisition is being conducted using policies unique to the acquisition of commercial items prescribed in FAR Part 12 in conjunction with the policies and procedures for the competition requirements in FAR Part 6. Interested parties may identify their interest and capabilities in response to this posting. The determination by the Government not to compete the proposed requirement based upon responses to this notice is solely within the discretion of the Government. Comments to this announcement, referencing this posting number, may be submitted to the CC, Office of Purchasing and Contracts, prior to the closing date specified in this announcement, electronically to the attention of Ivan Jones, Contract Specialist, ivan.jones@nih.gov by the due date and time marked in this notice.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/NIH/CCOPC/15-004134/listing.html)
 
Place of Performance
Address: 9000 Rockville Pike, Bethesda, Maryland, 20892, United States
Zip Code: 20892
 
Record
SN03675743-W 20150325/150323235048-537d856faf38f4c9fbade5802522c3ea (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.